Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.53 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KMO | O15229 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21982136 | 0.94 | CLK4 (0.48) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL18327488 | 0.94 | CLK4 (0.48) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL29637608 | 0.90 | CLK4 (0.57) | CLK4DYRK1AGP6NPC1RAB9A | |
| SCHEMBL14961829 | 0.90 | CLK4 (0.61) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL17720980 | 0.90 | MEN1 (0.47) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL18327459 | 0.90 | MEN1 (0.47) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL19075008 | 0.90 | MEN1 (0.47) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL19009562 | 0.88 | MEN1 (0.56) | CLK4DYRK1AGP6SMN1; SMN2KMO | |
| SCHEMBL18327356 | 0.87 | MEN1 (0.48) | CLK4DYRK1AGP6NPC1NFKB1 | |
| SCHEMBL19039933 | 0.87 | MEN1 (0.48) | CLK4DYRK1AGP6NPC1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114583067-A | Quantum dot light-emitting diode, display device and light-emitting light source | TCL科技集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114520292-A | Quantum dot light-emitting diode, display device and light-emitting light source | TCL科技集团股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| WO-1992001766-A1 | FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS CONTAINING HALOGENATED CORES AND CHIRAL HALOALKOXY TAIL UNITS | DISPLAYTECH, INC. (US) | 1992-02-06 | — | — | WO | claimed |
| CN-114583067-A | Quantum dot light-emitting diode, display device and light-emitting light source | TCL科技集团股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114520292-A | Quantum dot light-emitting diode, display device and light-emitting light source | TCL科技集团股份有限公司 | 2022-05-20 | — | — | CN | disclosed |
| US-10844086-B2 | Method for producing halogen-crosslinked iridium dimer | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-11-24 | — | — | US | disclosed |
| US-9666806-B2 | Formulations for the production of electronic devices | MERCK PATENT GMBH (DE) | 2017-05-30 | — | — | US | disclosed |
| EP-2168576-A2 | New utilities of tricyclic compounds | Shionogi & Co., Ltd. (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-20080318958-A1 | New utilities of tricyclic compounds | ISHIZUKA NATSUKI | 2008-12-25 | — | — | US | disclosed |
| US-20080318958-A1 | New utilities of tricyclic compounds | ISHIZUKA NATSUKI | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844086-B2 | Method for producing halogen-crosslinked iridium dimer | CYBA, CYBB, PPIB | CLK4 639/4885DYRK1A 49/4885GP6 2034/4885 |
| US-20080318958-A1 | New utilities of tricyclic compounds | APOB, PON1, APOL1 | CLK4 4118/4885DYRK1A 4365/4885GP6 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.